New York State Common Retirement Fund Acquires 24,916 Shares of Bruker Co. (NASDAQ:BRKR)

New York State Common Retirement Fund lifted its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 11.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 247,355 shares of the medical research company’s stock after purchasing an additional 24,916 shares during the period. New York State Common Retirement Fund owned 0.16% of Bruker worth $14,500,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Louisiana State Employees Retirement System raised its holdings in shares of Bruker by 11.3% during the third quarter. Louisiana State Employees Retirement System now owns 30,600 shares of the medical research company’s stock valued at $2,113,000 after purchasing an additional 3,100 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in Bruker by 109.9% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 13,110 shares of the medical research company’s stock valued at $905,000 after buying an additional 6,863 shares in the last quarter. Boston Trust Walden Corp acquired a new stake in Bruker in the third quarter valued at approximately $207,000. DekaBank Deutsche Girozentrale increased its holdings in shares of Bruker by 32.4% during the third quarter. DekaBank Deutsche Girozentrale now owns 307,040 shares of the medical research company’s stock valued at $21,516,000 after acquiring an additional 75,220 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in shares of Bruker by 5.6% during the third quarter. State of Alaska Department of Revenue now owns 42,686 shares of the medical research company’s stock worth $2,947,000 after purchasing an additional 2,245 shares during the period. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Trading Down 4.0 %

Shares of NASDAQ:BRKR opened at $50.82 on Monday. Bruker Co. has a 12-month low of $48.07 and a 12-month high of $94.86. The business’s fifty day simple moving average is $56.73 and its 200-day simple moving average is $60.03. The company has a market capitalization of $7.70 billion, a PE ratio of 66.87, a P/E/G ratio of 2.16 and a beta of 1.16. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, equities research analysts predict that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

BRKR has been the subject of several recent research reports. The Goldman Sachs Group upgraded Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target for the company in a report on Thursday, December 5th. Citigroup reduced their target price on Bruker from $80.00 to $75.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Wells Fargo & Company dropped their price target on Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a report on Wednesday, November 6th. TD Cowen cut their price target on shares of Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Finally, Stifel Nicolaus decreased their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating for the company in a report on Friday, February 14th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $70.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.